Liv.52 HB

Ayurveda texts and modern research back the following facts:

Action:

Antiviral action: The ingredients in Liv.52 HB suppress hepatitis B surface antigen (HBsAg) and clears the hepatitis B virus (HBV) by reverse transcriptase inhibition. It significantly lowers the overall viral load in chronic hepatitis B infection. Further, 6 months extended therapy gives comparatively better results in terms of viral clearance.

Hepatoprotective action: Liv.52 HB reverses the oxidative damage of hepatocytes and exerts an overall hepatoprotective action. It also renormalizes liver functions. Liv 52 HB normalizes liver enzyme levels and restores the hepatic glycogen levels.

Liv.52 was launched in 1955, and millions of physicians worldwide recommend Liv.52 (tablet, syrup, and drops forms), for various hepatic disorders. Liv.52 is an extensively researched product of The Himalaya Drug Company. Various clinical studies such as open clinical studies, randomized controlled studies, meta-analysis, as well as independent investigator initiated clinical studies (including those carried out abroad) have reported that Liv.52 is beneficial in various hepatic conditions. The product has more than 300 research articles published in scientific journals.

Each herbal ingredient of Liv.52 is been analyzed as per the standards set by Pharmacopoeia. The battery of non-clinical toxicological studies (acute, subacute, chronic, genotoxicity, developmental, and reproductive toxicity studies) have further reinforced the safety of Liv.52, with a wide margin. We ensure consistent quality in every batch (as per WHO standards for herbal medicine). Himalaya’s manufacturing facility is GMP certified and audited at regular intervals by several regulatory agencies around the world, wherever our products are marketed. Also, The Himalaya Drug Company’s advanced Research and Development (R&D) Center is certified for Good Laboratory Practices (GLP) for following international OECD guidelines.

With reference to heavy metals, considering some trace levels of heavy metals occurring naturally in botanical/ plants/ food ingredients, many regulatory agencies have defined the permissible limits for heavy metal contaminants in herbal medicines after considering the epidemiological aspects of such contaminants. In this direction, both WHO and AYUSH have defined the limits of heavy metals (NMT 10 ppm of lead) in Ayurvedic Medicines. We, at The Himalaya Drug Company, follow these guidelines for all our medicinal products and ensure that our products comply with these regulations. Apart from these, we align with the quality guidelines published by major regulatory agencies like USFDA (12.5mcg/day of lead), Health Canada (10 mcg/day of lead), HSA Singapore (10 ppm of lead), etc., to ensure highest quality of the product. The table below indicates the permitted levels of heavy metals by different international agencies, and Liv.52 complies with all the below mentioned standards.

Element	AYUSH	WHO	USFDA	HSA Singapore	Health Canada
Lead	10 ppm	10 ppm	12.5 mcg/day	10 ppm	10 mcg/day
Arsenic	3 ppm	-	-	5 ppm	10 mcg/day
Cadmium	0.3 ppm	0.3 ppm	-	0.3 ppm	6 mcg/day
Mercury	1 ppm	-	-	0.5 ppm	2 mcg/day

Please consult your physician to prescribe the dosage that best suits the condition.

Indications:

• Hepatitis B infection

  Side effects:

  Liv.52 HB is not known to have any side effects if taken as per the prescribed dosage.

  *The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.

The Himalaya Drug Company,
Makali,
Bengaluru - 562162

Manager - Customer Care
The Himalaya Drug Company
Makali,
Bengaluru
562 162

Email:
contactus@himalayawellness.com

Call 1-800-208-1930 (Toll-free in India)

www.himalayawellness.in